Navigation Links
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Date:6/2/2011

SAN DIEGO, June 2, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on May 31, 2011 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 411,750 shares of common stock to 27 new employees.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Each stock option has an exercise price per share equal to $14.51, the fair market value on the grant date, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and 1/48 of the shares vesting monthly thereafter, subject to the new employee's continued service relationship with the Company. Each stock option also has a ten year term and is subject to the terms and conditions of the Company's 2006 Equity Incentive Plan and the stock option agreement pursuant to which the option was granted.

The stock options were granted as inducements material to the new employees entering into employment with Optimer in accordance with NASDAQ Listing Rule 5635(c)(4).

About Optimer

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer has developed and plans to commercialize DIFICID™ (fidaxomicin) tablets, an FDA approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). CDAD is associated with a bacterial infection that is estimated to affect 700,000 people each year in the U.S. alone, and has surpassed MRSA as the leading cause of healthcare-acquired infections in community hospitals. Optimer has filed a marketing authorization app
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
2. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
3. Optimer Pharmaceuticals Expands Senior Management Team
4. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
5. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
6. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
7. Trading Halted Today in Optimer Pharmaceuticals Stock
8. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
9. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
10. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
11. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... WOODLANDS, Texas , May 28, 2015   ... today that Lexicon management will present at the Jefferies ... 8:00 a.m. Eastern Time in New York ... Lexicon,s clinical development programs and milestones. A ... website at www.lexpharma.com . An archived version of ...
(Date:5/28/2015)... Compassion & Choices today is pleased to report ... would authorize the option of medical aid in dying for ... The legislation, the End ... competent adults with six months or less to live the ... and peacefully end an unbearable dying process. A vote on ...
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015  Shareholder rights ... whether certain officers and directors of Eleven ... shareholders.  Eleven Biotherapeutics is a clinical-stage biopharmaceutical company ... protein therapeutics to treat eye diseases, primarily in ... View this press release on the ...
Breaking Medicine Technology:Lexicon To Present At The Jefferies 2015 Healthcare Conference 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2
... 7, 2011 Diplomat Specialty Pharmacy, the nation,s largest, privately ... of MichBio,s Good to Great Award. ... as a company whose business concept, entrepreneurialism, leadership, work ethic ... produce a leap forward in the past year," said Stephen ...
... EXTON, Pa., Nov. 7, 2011 Kensey Nash Corporation (Nasdaq: ... Small Business Innovation Research (SBIR) grant from the National Institutes ... Nash Corporation a two-year, $1.9 million Phase II SBIR grant ... for applications in tendon repair procedures.  The Company will develop ...
Cached Medicine Technology:Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 2Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 New ... from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) ... a new product line of peptide stable ... of Tryptides™, or isotope labeled tryptic peptides, offers ... interest and is now readily accessible to the ...
(Date:5/29/2015)... On May 28th, TheCelebrityDresses.com released their new ... party dresses. Most of the styles in their new ... more than 80 styles of sexy cocktail dresses and ... design elements coming with the new release are color ... design. Many of the new styles are made of ...
(Date:5/28/2015)... On Monday, June 1, KORT, The Best in ... in Shelbyville, Kentucky . Clinic Director, Chad Flickinger, PT, MPT, ... patients , “ Shelbyville is a growing community and ... to better serve the residents of Shelby County. At KORT, ... as possible by providing accessible and immediate care in a ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 External Counterpulsation ... and all over the United States. There are a ... disease, who can experience symptoms of angina and these ... heart stents and/or bypass surgery. , “No option” patients ... to coronary artery disease that is considered unacceptable for ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
Breaking Medicine News(10 mins):Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3
... latest study researchers say health professionals and patients require ... associated with over the counter drugs. Of the many ... most common condition that people choose to treat by ... commonly treated ailments include heartburn, migraine, period pain, coughs, ...
... started with a big bang, bringing hope and aspirations for people// ... own. 2001 opened with it Pandora ’s Box of ... first internationally reported disaster was in 2000 on February 1st in ... Soon after a whole string of disasters followed. ,Droughts ...
... a group of genes known as a gene signature, that ... at high risk for having a future cancer recurrence .// ... tumor samples from 209 lymph-node-negative breast cancer patients were examined. ... initial cancer treatment and varied in age and in their ...
... skin cancer – melanoma ,however researchers as the number of ... of patients surviving the disease. // Two new studies show ... of cancer. In a study conducted by researchers on patients ... was discovered that melanoma patients with higher levels of sun ...
... discovery could help prevent complications for pregnant women with ... after the 20th week of pregnancy and is characterized ... in the urine. In severe cases it can lead ... causes the mother to suffer a series of potentially ...
... study, advanced imaging techniques reveals unexpected structural differences in ... compared detailed images of the brain structure // of ... from 27 healthy patients. ,Results showed the amygdala ... research has linked to the brain's reward processing system ...
Cached Medicine News:Health News:SARS (Bird Flu) spreading in the Asian continent 2
... full weight. Footstep tilts out of the way ... raised and lowered by either a finger switch ... corded foot switch. Dual rotation locks on both ... the chair 330 without changing position. A patented ...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
Sandown chair, with hydraulic lift, sliding headrest and armrests with glides. Black vinyl....
Heine Beta 200 Streak Retinoscope 2.5v...
Medicine Products: